O
ONWARD Medical NV
F:63E
ONWARD Medical NV
F:63E
Price:
2.835
EUR
1.98%
Market Closed
Market Cap:
€98.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
ONWARD Medical NV
F:63E
|
NL |
|
S
|
Scor SE
XBER:SDRC
|
FR |
|
C
|
Central Japan Railway Co
F:JAP
|
JP |
|
N
|
Nebius Group NV
XMUN:YDX
|
NL |
|
P
|
Prudential Financial Inc
XMUN:PLL
|
US |
|
H
|
Heidelberg Pharma AG
DUS:HPHA
|
DE |
|
J
|
JAFCO Group Co Ltd
XMUN:JAF
|
JP |
|
C
|
Comtech Telecommunications Corp
SWB:CC6
|
US |
|
O
|
Osaka Gas Co Ltd
F:OSA
|
JP |
Wall St Price Targets
63E Price Targets Summary
ONWARD Medical NV
ONWARD Medical NV
Wall Street analysts forecast 63E stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 63E is 14.686 EUR with a low forecast of 12.044 EUR and a high forecast of 17.467 EUR.
Lowest Forecast
Price Target
12.044
EUR
325% Upside
Average Forecast
Price Target
14.686
EUR
418% Upside
Highest Forecast
Price Target
17.467
EUR
516% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 63E's stock price target?
Price Target
14.686
EUR
14.686
EUR
According to Wall Street analysts, the average 1-year price target for 63E is 14.686 EUR with a low forecast of 12.044 EUR and a high forecast of 17.467 EUR.
What is the Revenue forecast for ONWARD Medical NV?
Projected CAGR
153%
153%
The compound annual growth rate for Revenue over the next 3 years is 153%.
